Ellis Investment Partners’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,813
Closed -$49K 271
2022
Q3
$49K Buy
2,813
+81
+3% +$1.67K 0.01% 391
2022
Q2
$53K Buy
2,732
+71
+3% +$1.67K 0.01% 399
2022
Q1
$78K Sell
2,661
-272
-9% -$8.11K 0.02% 356
2021
Q4
$114K Buy
2,933
+2,622
+843% +$105K 0.03% 299
2021
Q3
$12K Buy
311
+4
+1% +$162 ﹤0.01% 577
2021
Q2
$12K Buy
307
+93
+43% +$3.52K ﹤0.01% 574
2021
Q1
$8K Sell
214
-588
-73% -$21.4K ﹤0.01% 602
2020
Q4
$29K Buy
+802
New +$24.7K 0.01% 442

Other funds holding BSTZ

Ellis Investment Partners's BSTZ Position: Q4 2022 in Review

Ellis Investment Partners sold out of BlackRock Science and Technology Term Trust (BSTZ) in Q4 2022, closing a stake of 2,813 shares — an estimated $49K sold.

Ellis Investment Partners first reported a position in BSTZ in Q4 2020 and held it in 8 quarters. The position peaked at $114K in Q4 2021. 104 funds tracked by Wall St. Rank hold BSTZ as of Q4 2022.

  • Ellis Investment Partners reported no remaining BlackRock Science and Technology Term Trust position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 2,813 BlackRock Science and Technology Term Trust shares in Q4 2022, an estimated $49K.
  • Ellis Investment Partners first reported a position in BlackRock Science and Technology Term Trust in Q4 2020 and held it in 8 quarters.
  • Ellis Investment Partners's BlackRock Science and Technology Term Trust position peaked at $114K in Q4 2021.
  • 104 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.